-
A multicenter, observational study retrospectively compared 59 individuals with acute or early HIV infection who elected to receive antiretroviral (ARV) therapy for 12 weeks to 337 patients who declined treatment.
-
Griel A, Kris-Etherton PM. Nuts reduce cardiovascular disease risk. Altern Med Alert 2007;10(3):28-34.
-
Patient handout: Heart disease is the No. 1 cause of death. Altern Med Alert 2007;10(3 Suppl):S1-S2.
-
Segre T, Schneider C. American ginseng (Panax quinquefolius) for upper respiratory tract infections. Altern Med Alert 2007;10(3):25-28.
-
Greenfield RH. Male and frail: Angdrogen supplementation? Altern Med Alert 2007;10(3):34-35. Greenfield RH. "Coffee no sugar"--Coffee and IGT. Altern Med Alert 2007;10(3):35-36.
-
This study from the excellent group at University of California in San Diego had standard population-based HIV genotyping performed on plasma obtained from all antiretroviral (ARV)-naïve patients who received care in publicly funded clinics in San Diego County during the 2005 calendar year.
-
A number of retrospective studies have provided evidence that, relative to therapy with semisynthetic penicillins such as nafcillin, vancomycin is inferior in the treatment of bactermic infections due to methicillin-susceptible Staphylococcus aureus (MSSA).
-
This interesting study from Denmark used data from the comprehensive Danish Civil Registration System to examine mortality in siblings of HIV/HCV-coinfected patients, HIV-monoinfected patients, and controls.
-
Citalopram Useful for Depression in CDA Patients; When to Stop Anticoagulation Before Surgery?; Drug Warnings: Ranibizumab and Bevacizumab; Growth Hormone Treatment, More Harm Than Good; FDA Actions
-
In an open label study, hospitalized adults with MRSA colonization at one or more sites were randomized (3:1) to attempted decolonization or no treatment. Treatment consisted of 7 days of bathing with 2% chlorhexidine gluconate, together with application of 2% mupirocin ointment to the anterior nares 3 times daily and administration of rifampin (300 mg twice daily) and doxycycline (100 mg twice daily).
